Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis

Multiple Sclerosis

Volumn 14, Issue 4, 2008, Pages 557-560

  Kawajiri, Masakazu ^a   Mogi, M ^a   Osoegawa, M ^b   Matsuoka, T ^b   Tsukuda, K ^a   Kohara, K ^a   Horiuchi, M ^a   Miki, T ^a   Kira, J I ^b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Cerebrospinal fluid; Multiple sclerosis

Indexed keywords

ANGIOTENSIN II;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHY; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; STATISTICAL ANALYSIS;

ANGIOTENSIN II; DISABILITY EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; NEURITIS; SEVERITY OF ILLNESS INDEX;

EID: 46749137551     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507085760     Document Type: Article

References (14)

1. Shao, J, Nangaku, M, Miyata, T, Inagi, R, Yamada, K, Kurokawa, K, et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31-38.
2. Constantinescu, CS, Ventura, E, Hilliard, B, Rostami, A. Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol 1995; 17: 471-491.
3. Mogi, M, Li, JM, Iwanami, J, Min, LJ, Tsukuda, K, Iwai, M, et al. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006; 48: 141-148.
4. Li, JM, Mogi, M, Tsukuda, K. Tomochika, H, Iwanami, J, Min, LJ, et al. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol 2007; 21: 499-511.
5. Asbury, AK, Cornblath, DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Review. Ann Neurol 1990; 27: S21-S24.
6. Ad Hoc American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1991; 41: 617-618.
7. Poser, CM, Paty, DW, Scheingerg, L, McDonald, WI, Davis, FA, Ebers, GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
8. McDonald, WI, Compston, A, Edan, G, Goodkin, D, Hartung, HP, Lublin, FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.
9. Kira, J, Kanai, T, Nishimura, Y, Yamasaki, K, Matsushita, S. Kawano, Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569-574.
10. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
11. Dalla Libera, L, Ravara, B, Angelini, A, Rossini, K, Sandri, M. Thiene, G, et al. Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. Circulation 2001; 103: 2195-2200.
12. Finkielman, S, Fischer-Ferraro, C, Diaz, A, Goldstein, DJ, Nahmod, VE. A pressor substance in the cerebrospinal fluid of normotensive and hypertensive patients. Proc Natl Acad Sci USA 1972; 69: 3341-3344.
13. Vervoort, VS, Beachem, MA, Edwards, PS, Ladd, S, Miller, KE, de Mollerat, X, et al. AGTR2 mutations in X-linked mental retardation. Science 2002; 296: 2401-2403.
14. Okuyama, S, Sakagawa, T, Chiaki, S, Imagawa, Y, Ichiki, T, Inagami, T. Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Res 1999; 821: 150-159.